Patents-Review.com
ClassID:

108837 ⎘

C12N7/06 - CPC Classification

Classification description:

Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof; Inactivation or attenuation; Producing viral sub-units by chemical treatment Inactivation or attenuation

Recent Application in this class:
#1
20250018023
2025-01-16

Zika Virus Vaccine

 #2
20240108712
2024-04-04

Zika virus vaccine

 #3
20230226165
2023-07-20

Zika virus vaccine

 #4
20230220356
2023-07-13

COMPOSITIONS AND METHODS FOR PRODUCING A VIRAL VACCINE WITH REDUCED PARTICLE SIZE

 #5
20230089695
2023-03-23

COMPOSITIONS IMMUNOGENIC AGAINST SARS CORONAVIRUS 2, METHODS OF MAKING, AND USING THEREOF

 #6
20230056142
2023-02-23

Virus purification

 #7
20230001014
2023-01-05

DETARGETED ADENOVIRUS VARIANTS AND RELATED METHODS

 #8
20220273786
2022-09-01

Zika virus vaccine

 #9
20210346441
2021-11-11

NON-REPLICATING VIRUS-DERIVED PARTICLES AND USES THEREOF

 #10
20210187092
2021-06-24

Stable vaccine compositions comprising inter alia live attenuated recombinant flavivirus and process for preparation thereof

 #11
20210095261
2021-04-01

Protein purification method and kit

 #12
20210093707
2021-04-01

Zika virus purification

 #13
20210069359
2021-03-11

Unit operation and use thereof

 #14
20200390888
2020-12-17

NOVEL AAV MEDIATED INFLUENZA VACCINES

 #15
20200384099
2020-12-10

Zika virus vaccine

 #16
20200368342
2020-11-26

Virus purification

 #17
20200197506
2020-06-25

Virus purification

 #18
20200017555
2020-01-16

ZIKA VIRUS VACCINE

 #19
20190388487
2019-12-26

Detargeted adenovirus variants and related methods

 #20
20190365767
2019-12-05

Combinations and methods comprising a capsid assembly inhibitor

 #21
20190022654
2019-01-24

METHOD FOR INCUBATING LIQUIDS

 #22
20190008945
2019-01-10

Zika virus purification

 #23
20180371027
2018-12-27

Zika virus vaccine

 #24
20180369359
2018-12-27

Virus purification

 #25
20180362937
2018-12-20

Virus purification

 #26
20180362936
2018-12-20

Zika virus purification

 #27
20180251769
2018-09-06

Recombinant Influenza Virus

 #28
20180243416
2018-08-30

AAV mediated influenza vaccines

 #29
20180243228
2018-08-30

Nanoparticle based vaccine strategy against swine influenza virus

 #30
20180099015
2018-04-12

Detargeted adenovirus variants and related methods

 #31
20180072997
2018-03-15

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

 #32
20170348411
2017-12-07

Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof

 #33
20170340642
2017-11-30

Combinations and methods comprising a capsid assembly inhibitor

 #34
20150320810
2015-11-12

Non-replicating virus-derived particles and uses thereof

 #35
20140107207
2014-04-17

Method for inactivating viruses with slightly acidic arginine

 #36
20130203152
2013-08-08

Method for reducing DNA impurities in viral compositions

 #37
20120015424
2012-01-19

Arginine inactivation of viruses

 #38
20110014233
2011-01-20

Psoralen-inactivated viral vaccine and method of preparation

 #39
20080318300
2008-12-25

Method for inactivating viruses with slightly acidic arginine

 #40
20060177909
2006-08-10

Preparation of immunoglobulin